FDA
approval
· 2020-12-28
FDA Approved: AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL — Supplemental Application (Alembic Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application to allow Alembic Pharmaceuticals to market a generic fixed-dose combination of amlodipine besylate and olmesartan me…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL)